AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model.
Saved in:
| Title: | AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model. |
|---|---|
| Authors: | Shaul JL; AgNovos Healthcare, Rockville, MD, United States of America., Hill RS; AgNovos Healthcare, Rockville, MD, United States of America., Bouxsein ML; Beth Israel Deaconess Medical Center, Boston, MA, United States of America., Burr DB; Indiana University, Indianapolis, IN, United States of America., Tilton AK; AgNovos Healthcare, Rockville, MD, United States of America. Electronic address: atilton@agnovos.com., Howe JG; AgNovos Healthcare, Rockville, MD, United States of America; University of Vermont, Burlington, VT, United States of America. |
| Source: | Bone [Bone] 2022 Jan; Vol. 154, pp. 116246. Date of Electronic Publication: 2021 Oct 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2763 |
|---|---|
| DOI: | 10.1016/j.bone.2021.116246 |
